Loading…
Medicare Prescription Drug Cost Equalization Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2008 · fourth_quarter · Medicare/Medicaid
Supported all provisions unless otherwise indicated: BOTH SENATE AND HOUSE S.2620, H.R. 5268, To provide a temporary increase of the Federal medical assistance percentage (FMAP) under the Medicaid program and for other purposes Supported all provisions unless otherwise indicated: BOTH SENATE AND HOUSE: S. 3101, H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 2102, H.R. 154, Ending the Medicare Disability Waiting Period Act of 2007 S. 3560, QI [Qualified Individuals] Program Supplemental Funding Act of 2008 H.R. 7110, Job Creation and Unemployment Relief Act of 2008 - supported provisions related to temporary FMAP increase SENATE ONLY: S. 2586, State Fiscal Relief Act of 2008, provisions relating to providing a temporary FMAP increase, freezing the Medicaid regulations and for other purposes S. 2819, Economic Recovery in Health Care Act of 2008 HOUSE ONLY: H.R. 5613, Protecting the Medicaid Safety Net Act of 2008 H.R. 6684, Medicare Prescription Drug Cost Equalization Act
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $7,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Medicare/Medicaid
H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues H.R. 758, Price Disclosure Regarding Treatment of Breast Cancer: transparency H.R. 2184, Enhanced Health Care Value for All Act of 2007: comparative effectiveness H.R. 3162, Children's Health and Medicare Protection Act of 2007: Medicaid rebate H.R. 4854, False Claims Act Correction Act of 2007: liability issues H.R. 5605, Physician Payments Sunshine Act of 2008: transparency issues H.R. 6684, Medicare Prescription Drug Cost Equalization Act: Part D issues H.R. 6752, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues S. 2029, Physician Payments Sunshine Act of 2007: transparency issues S. 2041, False Claims Act Correction Act of 2007: liability issues S. 3118, Preserving Access to Medicare Act of 2008: electronic prescribing, Part D data disclosure, and other issues S. 3396, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3408, Comparative Effectiveness Research Act of 2008: comparative effectiveness
Client expense: $6,170,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2008 · fourth_quarter · Medicare/Medicaid
P.L. 110-173: Medicare, Medicaid, and SCHIP Extension Act of 2007; S. 1164: Colon Cancer Screen for Life Act of 2007; H.R. 1926: Colon Cancer Screen for Life Act of 2007; CY2009 Physician Fee Schedule and SGR Issues; CY2009 Ambulatory Surgery Center payment issues; H.R. 3963: Children's Health Insurance Program Reauthorization of 2007; H.R. 6331: Medicare Improvements for Patients and Providers Act of 2008 (P.L. 110-275); H.R. 4879: Virtual Screening for Cancer Act of 2007; H.R. 6684: Medicare Prescription Drug Cost Equalization Act; issues regarding revisions to the National Cancer Act focusing on lethal cancers.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Medicare/Medicaid
H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues H.R. 758, Price Disclosure Regarding Treatment of Breast Cancer: transparency H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007: Medicaid rebate H.R. 2184, Enhanced Health Care Value for All Act of 2007: comparative effectiveness H.R. 3162, Children's Health and Medicare Protection Act of 2007: Medicaid rebate H.R. 4854, False Claims Act Correction Act of 2007: liability issues H.R. 5605, Physician Payments Sunshine Act of 2008: transparency issues H.R. 5683, The Government Accountability Office Act: disclosure of data H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008: comparative effectiveness, federal upper limit for Medicaid pharmacy reimbursement, electronic prescribing, Part D data disclosure, and other issues H.R. 6388 The Government Accountability Office Improvement Act of 2008: disclosure of data H.R. 6684, Medicare Prescription Drug Cost Equalization Act: Part D issues H.R. 6752, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues S. 558, Mental Health Parity Act of 2007: health insurance issues S. 2029, Physician Payments Sunshine Act of 2007: transparency issues S. 2041, False Claims Act Correction Act of 2007: liability issues S.3101, Medicare Improvements for Patients and Providers Act of 2008: comparative effectiveness, federal upper limit for Medicaid pharmacy reimbursement, electronic prescribing, Part D data disclosure, and other issues S. 3118, Preserving Access to Medicare Act of 2008: electronic prescribing, Part D data disclosure, and other issues S. 3396, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3408, Comparative Effectiveness Research Act of 2008: comparative effectiveness
Client expense: $5,420,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2008 · third_quarter · Medicare/Medicaid
P.L. 110-173: Medicare, Medicaid, and SCHIP Extension Act of 2007; S. 1164: Colon Cancer Screen for Life Act of 2007; H.R. 1926: Colon Cancer Screen for Life Act of 2007; CY2009 Physician Fee Schedule and SGR Issues; CY2009 Ambulatory Surgery Center payment issues; H.R. 3963: Children's Health Insurance Program Reauthorization of 2007; H.R. 6331: Medicare Improvements for Patients and Providers Act of 2008 (P.L. 110-275); H.R. 4879: Virtual Screening for Cancer Act of 2007; H.R. 6684: Medicare Prescription Drug Cost Equalization Act; Discussions regarding revisions to the National Cancer Act focusing on lethal cancers.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Health Issues
Advocated for passage of H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008. Advocated for passage of H.R. 3195 - ADA Amendments Act of 2008. Advocated for passage of H.R. 6485 - Timely Due Process for Disabled Act of 2008. Advocated for passage of H.R. 6684 - Medicare Prescription Drug Equalization Act.
Client expense: $81,213 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)